Inventor · disambiguated record
Changho Han
Also filed as: HAN CHANGHO
7 granted patents·10 pending applications·10 citations·filing 2016–2022
75Inventor score
Files withUNIV VANDERBILT17
Top patents by PatentIndex Score
17 records- 0186US12319701B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2020·Granted Jun 3, 2025·2 cites·20 claims
- 0284US10844044B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Nov 24, 2020·4 cites·20 claims
- 0378US10807959B2WDR5-MLL1 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Oct 20, 2020·2 cites·18 claims
- 0474US10221175B2Substituted pyrrolo[3,4-e]indolizines, imidazo[1,2-a]pyrrolo[3,4-e]pyridines, pyrrolo[3,4-e][1,2,4]triazolo[1,5-a]pyridines and pyrrolo[3,4-e][1,2,4]triazolo[4,3-a]pyridines as positive allosteric modulators of muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2016·Granted Mar 5, 2019·1 cites·19 claims
- 0572US11999716B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Jun 4, 2024·1 cites·12 claims
- 0657US2024228489A1Positive allosteric modulators of the muscarinic acetylcholine receptor m1UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 0757US2024140943A1Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 0854US2023183218A1Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 0954US2023183237A1Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1054US2023303552A1Arylsulfonyl derivatives and their use as muscarinic acetylcholine receptor m5 inhibitorsUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1154US2024174655A1Indazole derivatives as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1253US2024287050A1(4-(6-((2-octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)phenyl)(imino)(methyl)-lambda6- sulfanone derivatives and similar compounds as muscarinic acetylcholine receptor m4 antagonists for the treatment of neurodegenerative disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1351US2023183219A1Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1449US2023122344A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 1547US2023150986A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 1646US12398097B2WDR5-MYC inhibitorsUNIV VANDERBILT·Filed 2020·Granted Aug 26, 2025·0 cites·18 claims
- 1740US10342782B2Positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2017·Granted Jul 9, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Changho Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →